发明名称 |
Treatment of hepatitis B virus infection with human monoclonal antibodies |
摘要 |
Disclosed is a pharmaceutical composition for the treatment or prevention of hepatitis B virus infection, comprising a 1:3 mixture of two fully human anti HBsAg monoclonal antibodies 19.79.5 and 17.1.41. Also disclosed are preferred modes of administration. The pharmaceutical composition can be given as a monotherapy or in combination with other anti viral agents.
|
申请公布号 |
US2005260195(A1) |
申请公布日期 |
2005.11.24 |
申请号 |
US20050056186 |
申请日期 |
2005.02.14 |
申请人 |
XTL BIOPHARMACEUTICALS LTD. |
发明人 |
DAGAN SHLOMO;EREN RACHEL |
分类号 |
A61K39/42;C07K16/08;C12Q1/70;(IPC1-7):A61K39/42 |
主分类号 |
A61K39/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|